Efficacy and safety of electronic cigarettes for smoking cessation: A critical approach

Hellenic Journal of Cardiology

Volumn 57, Issue JANUARY-FEBRUARY, 2016, Pages 1-6

  Ioakeimidis, Nikolaos ^a   Vlachopoulos, Charalambos ^a   Tousoulis, Dimitris ^a  

^a HIPPOKRATION HOSPITAL   (Greece)

Author keywords

Brugada syndrome; Channelopathies; Long QT syndrome; Prevalence; Sudden infant death; Tachycardia; Ventricular

Indexed keywords

ACETALDEHYDE; FORMALDEHYDE; GLYCEROL; HEAVY METAL; NICOTINE; PROPYLENE GLYCOL; TOBACCO SMOKE;

CARDIOVASCULAR DISEASE; ELECTRONIC CIGARETTE; HUMAN; LUNG DISEASE; MEDICAL LITERATURE; PUBLIC HEALTH; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SAFETY; SMOKING CESSATION; SYSTEMATIC REVIEW; ADVERSE EFFECTS; CARDIOVASCULAR DISEASES; PROCEDURES; TRENDS; YOUNG ADULT;

CARDIOVASCULAR DISEASES; ELECTRONIC CIGARETTES; HUMANS; SMOKING CESSATION; YOUNG ADULT;

EID: 84957673984     PISSN: 11099666     EISSN: 22415955     Source Type: Journal    
DOI: 10.1016/s1109-9666(16)30011-2     Document Type: Review

References (40)

1. Rigotti NA, Clair C. Managing tobacco use: the neglected cardiovascular disease risk factor. Eur Heart J. 2013; 34: 3259-3267.
2. Panagiotakos DB, Georgousopoulou EN, Fitzgerald AP, Pitsavos C, Stefanadis C. Validation of the HellenicSCORE (a Calibration of the ESC SCORE Project) Regarding 10-Year Risk of Fatal Cardiovascular Disease in Greece. Hellenic J Cardiol. 2015; 56: 302-308.
3. Chrysohoou C. Are Cardiac Risk Scores Useful in Daily Clinical Practice? Hellenic J Cardiol. 2015; 56: 309-310.
4. Wender R, Fontham ET, Barrera E Jr, et al. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin. 2013; 63: 107-117.
5. Musk AW, de Klerk NH. History of tobacco and health. Respirology. 2003; 8: 286-290.
6. Peletidi A, Nabjani S, Kayyali R. Smoking cessation support services at community pharmacies in the UK. A systematic review. Hellenic J Cardiol. 2016; 57: 1-9.
7. Grana R, Benowitz N, Glantz SA. E-cigarettes: a scientific review. Circulation. 2014; 129: 1972-1986.
8. Crowley RA; Health Public Policy Committee of the American College of Physicians. Electronic nicotine delivery systems: executive summary of a policy position paper from the American College of Physicians. Ann Intern Med. 2015; 162: 583-584.
9. Orellana-Barrios MA, Payne D, Mulkey Z, Nugent K. Electronic Cigarettes-A Narrative Review for Clinicians. Am J Med. 2015; 128: 674-681.
10. Farsalinos K, Spyrou A, Tsimopoulou K, Stefopoulos C, Romagna G, Voudris V. Nicotine absorption from electronic cigarette use: comparison between first and new-generation devices. Sci Rep. 2014; 4: 4133.
11. Brandon TH, Goniewicz ML, Hanna NH, et al. Electronic nicotine delivery systems: a policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology. Clin Cancer Res. 2015; 21: 514-525.
12. Bhatnagar A, Whitsel LP, Ribisl KM, et al; American Heart Association Advocacy Coordinating Committee, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Quality of Care and Outcomes Research. Electronic cigarettes: a policy statement from the American Heart Association. Circulation. 2014; 130: 1418-1436.
13. Bunnell RE, Agaku IT, Arrazola RA, et al. Intentions to smoke cigarettes among never-smoking US middle and high school electronic cigarette users: National Youth Tobacco Survey, 2011-2013. Nicotine Tob Res. 2015; 17: 228-235.
14. McRobbie H, Bullen C, Hartmann-Boyce J, Hajek P. Electronic cigarettes for smoking cessation and reduction. Cochrane Database Syst Rev. 2014; 12: CD010216.
15. Rahman MA, Hann N, Wilson A, Mnatzaganian G, Worrall-Carter L. E-cigarettes and smoking cessation: evidence from a systematic review and meta-analysis. PLoS One. 2015; 10: e0122544.
16. Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Voudris V. Characteristics, perceived side effects and benefits of electronic cigarette use: a worldwide survey of more than 19,000 consumers. Int J Environ Res Public Health. 2014; 11: 4356-4373.
17. Biener L, Hargraves JL. A longitudinal study of electronic cigarette use among a population-based sample of adult smokers: association with smoking cessation and motivation to quit. Nicotine Tob Res. 2015; 17: 127-133.
18. Caponnetto P, Campagna D, Cibella F, et al. EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One. 2013; 8: e66317.
19. Polosa R, Morjaria JB, Caponnetto P, et al. Effectiveness and tolerability of electronic cigarette in real-life: a 24-month prospective observational study. Intern Emerg Med. 2014; 9: 537-546.
20. Brose LS, Hitchman SC, Brown J, West R, McNeill A. Is the use of electronic cigarettes while smoking associated with smoking cessation attempts, cessation and reduced cigarette consumption? A survey with a 1-year follow-up. Addiction. 2015; 110: 1160-1168.
21. Borderud SP, Li Y, Burkhalter JE, Sheffer CE, Ostroff JS. Electronic cigarette use among patients with cancer: characteristics of electronic cigarette users and their smoking cessation outcomes. Cancer. 2014; 120: 3527-3535.
22. Manzoli L, Flacco ME, Fiore M, et al. Electronic Cigarettes Efficacy and Safety at 12 Months: Cohort Study. PLoS One. 2015; 10: e0129443.
23. Bullen C, Howe C, Laugesen M, et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet. 2013; 382: 1629-1637.
24. Polosa R. Electronic cigarette use and harm reversal: emerging evidence in the lung. BMC Med. 2015; 13: 54.
25. Electronic nicotine delivery systems: report by WHO (FCTC/ COP/6/10 Rev.1). Sixth session of the Conference of the Parties to the WHO Framework Convention on Tobacco Control, Moscow, Russian Federation, 13-18 October, 2014. Geneva: World Health Organization; 2014. Available from: http://apps.who.int/gb/fctc/PDF/cop6/FCTC_COP6_10Rev1-en.pdf [Accessed 9 June 2015].
26. Kohler M. Electronic cigarettes: the pulmonologist’s point of view. Eur Heart J. 2015; 36: 137.
27. Lippi G, Favaloro EJ, Meschi T, Mattiuzzi C, Borghi L, Cervellin G. E-cigarettes and cardiovascular risk: beyond science and mysticism. Semin Thromb Hemost. 2014; 40: 60-65.
28. Middlekauff HR, Park J, Moheimani RS. Adverse effects of cigarette and noncigarette smoke exposure on the autonomic nervous system: mechanisms and implications for cardiovascular risk. J Am Coll Cardiol. 2014; 64: 1740-1750.
29. Yan XS, D’Ruiz C. Effects of using electronic cigarettes on nicotine delivery and cardiovascular function in comparison with regular cigarettes. Regul Toxicol Pharmacol. 2015; 71: 24-34.
30. Farsalinos KE, Tsiapras D, Kyrzopoulos S, Savvopoulou M, Voudris V. Acute effects of using an electronic nicotine-delivery device (electronic cigarette) on myocardial function: comparison with the effects of regular cigarettes. BMC Cardiovasc Disord. 2014; 14: 78.
31. Nelluri BK, Murphy K, Mookadam F. Electronic cigarettes and cardiovascular risk: hype or up in smoke? Future Cardiol. 2015; 11: 271-273.
32. Vlachopoulos C, Kosmopoulou F, Panagiotakos D, et al. Smoking and caffeine have a synergistic detrimental effect on aortic stiffness and wave reflections. J Am Coll Cardiol. 2004; 44: 1911-1917.
33. Vlachopoulos C, Alexopoulos N, Panagiotakos D, O’Rourke MF, Stefanadis C. Cigar smoking has an acute detrimental effect on arterial stiffness. Am J Hypertens. 2004; 17: 299-303.
34. Vlachopoulos C, Aznaouridis K, Bratsas A, et al. Arterial stiffening and systemic endothelial activation induced by smoking: The role of COX-1 and COX-2. Int J Cardiol. 2015; 189: 293-298.
35. Siasos G, Tousoulis D, Vlachopoulos C, et al. The impact of oral L-arginine supplementation on acute smoking-induced endothelial injury and arterial performance. Am J Hypertens. 2009; 22: 586-592.
36. Stefanadis C, Tsiamis E, Vlachopoulos C, et al. Unfavorable effect of smoking on the elastic properties of the human aorta. Circulation. 1997; 95: 31-38.
37. Warren GW, Singh AK. Nicotine and lung cancer. J Carcinog. 2013; 12: 1.
38. Goniewicz ML, Knysak J, Gawron M, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control. 2014; 23: 133-139.
39. Uchiyama S, Ohta K, Inaba Y, Kunugita N. Determination of carbonyl compounds generated from the E-cigarette using coupled silica cartridges impregnated with hydroquinone and 2,4-dinitrophenylhydrazine, followed by high-performance liquid chromatography. Anal Sci. 2013; 29: 1219-1222.
40. Kosmider L, Sobczak A, Fik M, et al. Carbonyl compounds in electronic cigarette vapors: effects of nicotine solvent and battery output voltage. Nicotine Tob Res. 2014; 16: 1319-1326.